Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

2,774 public trials 698 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

PET Scans in Patients With Diffuse Large B-Cell Lymphoma Receiving Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone

NCT00544219

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • European Institute of Oncology Milan, Italy
  • Hirslanden Klinik Aarau Aarau, Switzerland
  • Kantonspital Aarau Aarau, Switzerland
  • Kantonsspital Baden Baden, Switzerland
View all 19 locations
View Trial Details
Completed

Study To Evaluate Pf-04965842 In Subjects With Moderate To Severe Atopic Dermatitis

NCT02780167

Conditions
Atopic Dermatitis, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Dermatitis, +18 more
Locations
  • Clinical Research Center of Alabama Birmingham, Alabama, United States
  • California Dermatology & Clinical Research Institute Encinitas, California, United States
  • Huntington Medical Foundation Pasadena, California, United States
  • Peninsula Research Associates, Inc. Rolling Hills Estates, California, United States
View all 64 locations
View Trial Details
Completed

A Study Evaluating The Efficacy And Safety Of CP-690,550 In Asian Subjects With Moderate To Severe Plaque Psoriasis

NCT01815424

Conditions
Bronchial Diseases, Bronchiolitis, Bronchiolitis Obliterans, +25 more
Locations
  • Dept. Of dermatology &STD, Beijing Friendship Hospital, Capital Medical University Xicheng District, Beijing Municipality, China
  • Sun Yat-Sen Memorial Hospital, Sun Yat-Sen University Guangzhou, Guangdong, China
  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
  • Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
View all 24 locations
View Trial Details
Completed

A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents

NCT02745769

Conditions
Advanced Cancer, Colonic Diseases, Colorectal Cancer, +20 more
Locations
  • UAB Comprehensive Cancer Center Birmingham, Alabama, United States
  • University of Texas MD Anderson Cancer Center Houston, Texas, United States
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Lyon, France
  • For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician. Marseille, France
View Trial Details
Completed

Alemtuzumab and CHOP in T-cell Lymphoma

NCT00646854

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • AKH Linz Linz, Austria
  • Krankenhaus der Elisabethinen Linz, Austria
  • Center for Clinical Cancer and Immunology Trials Salzburg, Austria
  • Hanusch Krankenhaus Vienna, Austria
View all 59 locations
View Trial Details

Related conditions